E-nside TAAA MultiBranch Stent Graft System - Graft, vascular, synthetic
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
22-10-2021
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Cryolife Medical (Australia) Company Pty Ltd
Klassi:
Class III
Manifatturat minn:
Jotec GmbH Lotzenacker 23, Hechingen, 72379 Germany
Żona terapewtika:
35281 - Graft, vascular, synthetic
Indikazzjonijiet terapewtiċi:
The E-nside stent graft is delivered sterile, loaded in a delivery system. It is a self-expanding stent graft remaining in the body after deployment. The implant is available in various sizes which differ in their proximal and distal diameters. The E-nside TAAA Multibranch Stent Graft System is indicated for endovascular treatments of patients with thoracoabdominal aortic aneurysms.
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2021-09-08
